* IL-1β levels were significantly increased in the T2DM group (P= 0.019) in early middle aged (31-40 years) and not effected in late middle aged (41-50 years) (P=0.167).* IL-1β did not show a significant association with ageing among the T2DM group. Here, IL1B is linked to type 2 diabetes mellitus.